Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.
about
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTAntiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
P2860
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@en
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@nl
type
label
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@en
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@nl
prefLabel
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@en
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@nl
P2093
P2860
P356
P1433
P1476
Once-daily abacavir/lamivudine ...... bjects: a 48-week pilot study.
@en
P2093
Belinda Ha
COL40263 Study Team
Calvin Cohen
Edwin DeJesus
Joseph Gathe
Randall E Lanier
Richard Elion
P2860
P304
P356
10.1310/HCT0706-324
P577
2006-11-01T00:00:00Z